Infinium Pharmachem Ltd. Stock Analysis INFINIUM.NS

Infinium Pharmachem Ltd. engages in the business of manufacturing and supply of Iodine based Pharmaceutical derivatives. The company is headquartered in Anand, Gujarat and currently employs 144 full-time employees. The company went IPO on 2023-04-17. The firm is engaged in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe. Its portfolio includes approximately 200+ Iodine Derivatives and seven Active Pharmaceutical Ingredients (APIs). The company manufactures and supplies a range of Iodine-based APIs, but on an Order-to-Made basis only. The company offers Bulk Actives, intermediates and services for custom synthesis. The company also provides contract research and manufacturing services to pharmaceutical and biotech companies for their diverse requirements of Iodine-based APIs and intermediates to reduce their research time and project cost. The company manufactures iodine derivatives for various industries, including pharmaceutical, chemical, nutraceutical, cosmetics, sanitation, agrochemical, electronics, nylon production, and other industries for their range of industrial applications.